Seizure frequency higher with JWH-018
The researchers came to their findings by analyzing the brain activity of male mice after they received THC or JWH-018.
THC was given to the rodents in doses of 10 milligrams per kilogram (the equivalent to around 0.8 milligrams per kilogram in humans) and JWH-018 was administered in doses of 2.5 milligrams per kilogram (the equivalent to around 0.2 milligrams per kilograms in humans).
The team implanted electroencephalography (EEG) and electromyogram electrodes into the brains of the mice, which allowed them to monitor any seizure-related electrical activity in response to the drug compounds.
The movement and behavior of the rodents were also monitored through video recording.
The study revealed that the mice experienced seizures shortly after administration with both THC and JWH-018, through seizure frequency was significantly higher with JWH-018.
Seizure-related brain activity persisted for 4 hours after the administration of each drug, the team reports, but brain activity had returned to normal by the next day. Interestingly, the researchers found that pre-treating the mice with AM-251 – which is a compound that binds to the cannabinoid-1-receptor – prevented seizures in response to THC and JWH-018. As such, the team suggests that cannabinoid receptor antagonists could be useful for preventing seizures in the case of marijuana overdose.
The study warns of possible dangers
According to the researchers, their results “provide strong evidence” that both plant-derived and synthetic cannabinoids have the potential to trigger seizures. “On the other hand,” the authors note, “a substantial body of literature on cannabinoids in animal models shows mostly anticonvulsive effects.”
“However,” they add, “few of these used EEG recordings to assess epileptic events and many of them induced seizures either electrically or pharmacologically, changing signaling pathways and brain states prior to cannabinoid application.”
The team cautions that the doses of THC and JWH-018 used in their study were high and may not represent the doses normally seen with medicinal or recreational use in humans.
“It would be interesting in the future to also test lower doses, typically used medicinally or recreationally to determine whether the effect is lost or diminished,” they add. Still, they believe that their findings should be viewed as a warning of the potential dangers of cannabinoids, particularly synthetic marijuana.
“Our study is quite important because unaware of the particularly severe effect by those cannabinoids, people see marijuana as a soft drug, without dangerous health effects.”